The 'biodrug' concept: An innovative approach to therapy

Trends in Biotechnology

Volumn 19, Issue 10, 2001, Pages 393-400

  Blanquet, Stéphanie ^a   Marol Bonnin, Sylvie ^c   Beyssac, Eric ^a   Pompon, Denis ^b   Renaud, Michel ^a   Alric, Monique ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CNRS   (France)

^c Digestar Company   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIGESTIVE SYSTEM; ENZYMES; GENETIC ENGINEERING; MICROORGANISMS;

GASTROINTESTINAL TRACTS;

DRUG THERAPY;

CYTOCHROME P450 1A1; CYTOCHROME P450 73A1; INTERLEUKIN 10; KLEBSIELLA AEROGENES UREASE; LACTOBACILLUS VACCINE; LACTOCOCCUS LACTIS VACCINE; PNEUMOCOCCUS VACCINE; SALMONELLOSIS VACCINE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VACCINE;

BIOTECHNOLOGY; DRUG DEVELOPMENT;

BACTERIUM; BIOSYNTHESIS; COLITIS; DETOXIFICATION; DIGESTION; DRUG SCREENING; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE TECHNOLOGY; GENETIC ENGINEERING; HUMAN; KIDNEY FAILURE; MODEL; NONHUMAN; PANCREAS DISEASE; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SIMULATION; STREPTOCOCCUS PNEUMONIA; TETANUS; YEAST;

ARTIFICIAL ORGANS; BIOLOGICAL THERAPY; DIGESTIVE SYSTEM; GENE THERAPY; HUMANS; LACTOBACILLACEAE; SACCHAROMYCES CEREVISIAE;

EID: 0035478927     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(01)01739-5     Document Type: Review

References (36)

1. The application of genetically engineered microorganisms in the production of drugs
2. Therapeutic uses of microencapsulated genetically engineered cells
3. Future directions for research on biotherapeutic agents: Contribution of genetics approaches on lactic acid bacteria
4. Saccharomyces boulardii: A review of an innovative biotherapeutic agent
5. Environmental potential of suicide genes
6. Controlled overproduction of proteins by lactic acid bacteria
7. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403
8. Life with 6000 genes
9. Simulation of human xenobiotic metabolism in micro-organisms. Yeast a good compromise between E. coli and human cells
10. Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast
11. Strategies for the genetic manipulation of Saccharomyces cerevisiae
12. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract
13. Digestion and absorption of food: Usefulness and limitations of in vitro models
14. Critical evaluation of in vitro methods for estimating digestibility in simple-stomach animals
15. A multicompartmental dynamic computer-controlled model stimulating the stomach and small intestine
16. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products
17. Estimation of the bioavailability of iron and phosphorus in cereals using a dynamic in vitro gastrointestinal model
18. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: Validation and the effects of bile
19. Characterization of recombinant plant cinnamate 4-hydroxylase produced in yeast. Kinetic and spectral properties of the major plant P450 of the phenylpropanoid pathway
20. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells
21. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae
22. Recombinant live Salmonella spp. for human vaccination against pathogens
23. Expression of the protective antigen of Bacillus anthracis by Lactobactillus casei: Towards the development of an oral vaccine against anthrax
24. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis
25. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
26. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases
27. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes
28. Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin
29. Yeast expressing hepatitis B virus surface antigen determinants on its surface: Implications for a possible oral vaccine
30. Study of gene transfer in vitro and in the digestive tract of gnotobiotic mice from Lactococcus lactis strains to various strains belonging to human intestinal flora
31. Protein glycosylation in yeast
32. Kinetics of Saccharomyces cerevisiae elimination from the intestines of Human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice
33. Probiotics: Determinants of survival and growth in the gut
34. Analysis of gastric emptying data